Date of Submission
Academic Programs and Concentrations
Project Advisor 1
Project Advisor 2
Cisplatin is a commonly used chemotherapeutic drug with a platinum metal center. While it is effective as an anti-cancer agent, it also has a host of unwanted side-effects. A possible cause of some side-effects may be due to the lack of selectivity of cisplatin, therefore research to find an alternative that is not only less cytotoxic to normal cells but also more likely to specifically target cancer cells has intensified. The compounds in this study contain two metal centers, both ruthenium and iron. The ruthenium center may help facilitate specificity and may have an anti-metastasis effect. The iron core may act as a cytotoxic moiety of the compound. Overall the compounds are expected to have lower toxicity to normal cells. Three ruthenium-ferrocene compounds were synthesized and tested in biological assays for cytotoxic and anti-metastatic effects.
Open Access Agreement
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Chen, Kody Eric, "Synthesis and Assays of Potential Anti-Cancer Ruthenium-Ferrocene Compounds" (2015). Senior Projects Spring 2015. 126.